{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:27:37Z","timestamp":1778426857136,"version":"3.51.4"},"reference-count":13,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1814,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1111\/j.1440-1827.2010.02597.x","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T07:46:43Z","timestamp":1284364003000},"page":"774-778","source":"Crossref","is-referenced-by-count":2,"title":["Frequent expression of gp46 in adult T-cell leukemia\/lymphoma: An immunohistochemical study of 40 cases"],"prefix":"10.1111","volume":"60","author":[{"given":"Junichi","family":"Kiyasu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensaku","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshizo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Hashikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Niino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,13]]},"reference":[{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB1|cit1","first-page":"281","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Ohshima","year":"2008"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","article-title":"Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Utsunomiya","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2141.2003.04054.x","article-title":"Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia\/lymphoma","volume":"120","author":"Kami","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.bmt.1705197","article-title":"Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia\/lymphoma","volume":"37","author":"Nakase","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","article-title":"Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma","volume":"105","author":"Okamura","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<539::AID-PATH465>3.0.CO;2-T","article-title":"Survival of patients with HTLV-1-associated lymph node lesions","volume":"189","author":"Ohshima","year":"1999","journal-title":"J Pathol"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1349-7006.2006.00370.x","article-title":"Antibody to the central region of human T-lymphotropic virus type 1 gp46 is associated with the progression of adult T-cell leukemia","volume":"98","author":"Sagara","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2141.1998.00761.x","article-title":"Nodal T-cell lymphoma in an HTLV-1-endemic area: Proviral HTLV-1 DNA, histological classification and clinical evaluation","volume":"101","author":"Ohshima","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-05-1352","article-title":"Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: Comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL","volume":"103","author":"Tsuchiya","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1349-7006.2008.01061.x","article-title":"Involvement of molecular mimicry between human T-cell leukemia virus type 1 gp46 and osteoprotegerin in induction of hypercalcemia","volume":"100","author":"Sagara","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB11|cit11","first-page":"594","article-title":"Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia","volume":"9","author":"Sadamori","year":"1995","journal-title":"Leukemia"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB12|cit12","first-page":"598","article-title":"p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia","volume":"9","author":"Nishimura","year":"1995","journal-title":"Leukemia"},{"key":"10.1111\/j.1440-1827.2010.02597.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1349-7006.2004.tb02190.x","article-title":"Novel biomarker of HTLV-1-associated disease: Specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein","volume":"95","author":"Sagara","year":"2004","journal-title":"Cancer Sci"}],"container-title":["Pathology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1827.2010.02597.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1440-1827.2010.02597.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T22:08:14Z","timestamp":1613426894000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1440-1827.2010.02597.x"}},"subtitle":["Frequent expression of gp46 in ATLL"],"short-title":[],"issued":{"date-parts":[[2010,9,13]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1440-1827.2010.02597.x","relation":{},"ISSN":["1320-5463"],"issn-type":[{"value":"1320-5463","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,13]]}}}